Alex Vujin, Senior Medical Writer with a PhD in molecular genetics from McGill University, continues his discussion of CAR T-cell therapy with Malcolm Beasley, Principal at PCI.
Alex examines the scientific, clinical, and logistical limitations currently facing CAR T therapy, including antigen escape, tumor microenvironment challenges in solid tumors, and manufacturing bottlenecks that can delay treatment by weeks. The conversation explores next-generation solutions such as armored CAR T cells, dual-targeting bispecific designs, CRISPR gene editing, and the development of off-the-shelf allogeneic products that could dramatically reduce costs and expand access. Malcolm discusses the educational imperative for healthcare professionals navigating this complex field and PCI Medical's approach to delivering training through digital learning hubs, animated explainer videos, and modular content for pharma teams.
Essential viewing for oncology and hematology professionals, pharmaceutical medical affairs staff, and anyone involved in cell therapy education and the future of cancer immunotherapy.
Please Click the Thumbnail to Watch the Full Video
Videos
Alex Vujin, Senior Medical Writer with a PhD in molecular genetics from McGill University, provides a comprehensive overview of CAR T-cell therapy with Malcolm Beasley, Principal at PCI.
Alex explores the revolutionary science behind chimeric antigen receptor T-cell therapy, from its origins in the late 1980s to seven FDA-approved products today, including the landmark case of Emily Whitehead. The conversation covers the manufacturing process, clinical impact showing 70-90% response rates in previously treatment-resistant patients, and key challenges including cytokine release syndrome, antigen escape, and the high cost of personalized treatment. Malcolm discusses the educational challenges facing healthcare professionals and PCI Medical's approach to developing digital learning hubs, clinical insight videos, and training resources for pharma teams.
Essential viewing for oncology and hematology professionals, pharmaceutical medical affairs staff, and anyone involved in cell therapy education and training.
Please Click the Thumbnail to Watch the Full Video
Dr. Louis Aronne, Sanford I. Weill Professor of Metabolic Research at Weill Cornell Medical College, discusses the rapid evolution of obesity medicine with Malcolm Beasley, CEO of PCI.
Dr. Aronne explores breakthrough results with GLP-1 agonists, including dramatic reductions in diabetes risk and cardiovascular mortality, and emphasizes the need to treat obesity as a chronic disease. The conversation covers educational gaps among healthcare providers and pharma medical affairs staff, managing treatment side effects, and PCI Medical's collaboration with The Obesity Society to provide comprehensive training resources through their clinical handbook and educational programs.
Essential viewing for healthcare providers, pharmaceutical professionals, and anyone involved in obesity education and treatment.
Please Click the Thumbnail to Watch the Full Video
Dr. Gary Marshall, Professor of Pediatrics at the University of Louisville and author of the Vaccine Handbook, discusses the critical need for evidence-based vaccine education with Malcolm Beasley, CEO of PCI.
The conversation covers combating vaccine misinformation, the evolution of the Vaccine Handbook ("The Purple Book") through 12 editions, and the expansion of available pediatric to adult vaccines. Dr. Marshall emphasizes the importance of trusted sources and effective communication with hesitant patients, while highlighting partnerships with professional societies like the Pediatric Infectious Diseases Society.
The discussion explores educational tools including digital learning hubs, clinical insight videos, and an AI-powered Q&A chatbot built on the handbook's content to provide real-time guidance for healthcare providers. Essential viewing for healthcare professionals, medical educators, and pharmaceutical teams involved in vaccine communication and training.
Please Click the Thumbnail to Watch the Full Video
.png)
Join Malcolm Beasley and Jenny Cai for insights on effective HCP education strategies in pharma. This 30-minute webinar explores how to address healthcare providers' top priority: educational support.
Topics include:
-
Understanding HCP knowledge gaps and unmet needs
-
Creating engaging educational materials that drive impact
-
Innovative digital resources: learning hubs, clinical insight videos, case studies, and mobile apps
-
Leveraging KOL involvement for credibility
-
Multi-channel dissemination strategies
-
Measuring engagement and ROI
Discover best practices for developing evidence-based content that helps HCPs stay current, improve their practice, and enhance patient outcomes. Learn how to navigate regulatory review and maximize reach through targeted distribution.
Please Click the Thumbnail to Watch the Full Video
Join Malcolm Beasley and Jenny Cai for insights on transforming complex clinical data into engaging, actionable training for pharma sales teams.
Topics include:
-
Tailoring materials for new hires, seasoned reps, MSLs, and brand managers
-
Converting dense scientific content into digestible resources
-
Innovative approaches: gamification, storytelling, visual learning, and experiential simulations
-
Real-world case studies: escape room workshops, patient experience videos, and war game scenarios
-
Balancing regulatory compliance with creative delivery
-
Leveraging KOL involvement for credibility
Discover proven techniques for moving beyond traditional presentations to create cost-effective, engaging training that drives retention and performance.
Please Click the Thumbnail to Watch the Full Video
Partner With Us
Whether you're a medical society, association, or disease advocacy group, PCI has the expertise to help you deliver exceptional educational resources to your members. Contact us today to discuss how we can support your mission.